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with Symptomatic Peripheral Arterial DiseaseOur debaters have argued their preferred approaches for
younger patients with symptomatic peripheral arterial disease
(PAD) and have included such issues as procedure related
morbidity, patency and durability, reinterventions and life expec-
tancy. A similar discussion could occur regarding younger patients
with abdominal aortic aneurysms and the comparative value of an
endovascular or open repair. However, this analogy is not entirely
appropriate. Whereas durability of the repair and need for reinter-
vention are especially relevant in these young aneurysm patients,
with their longer life expectancies, young PAD patients represent
a group with more aggressive systemic atherosclerotic disease. At
best, these younger patients can expect an absolute life expectancy
similar to their older symptomatic PAD counterparts.1
The early presentation of symptomatic PAD is a marker of coin-
ciding premature atherosclerotic disease in the coronary and
carotid circulations. Medical therapy and risk factor modiﬁcation
is especially vital in these patients regardless of the operative or
interventional approach used for their PAD. Speciﬁc risk factors,
including Lp (a) lipoprotein level >30 mg/dl, have been identiﬁed
as risk factors for premature PAD, especially in men.2 Despite
adequate medical therapy and diabetes management, these
patients are at increased risk for major cardiovascular events.
Recent evidence would suggest that young women with PAD are
especially susceptible to cardiovascular events compared to men,
whereas risks are more similar in older age groups.3
Along with a more aggressive form of systemic atherosclerotic
disease, young PAD patients appear to be predisposed to multiple
procedures or interventions. In a review of a group of younger
men with symptomatic PAD, 40% required multiple interventions
because of progression of their disease or bypass graft failure.1
Predictors of treatment failure have been investigated recently. In
a cohort of Chinese patients, 38% of young PAD patients had throm-
bophilia that proved to be an independent predictor of graft throm-
bosis and major amputation at 30 days, and decreased patency and
limb salvage after one year.4
Young patients with symptomatic PAD represent an especially
challenging group of patients for vascular surgeons. As with older
patients they represent a population with aggressive systemic
atherosclerosis and a somewhat limited life expectancy. Aggressive
medical therapy and risk factor modiﬁcation is mandatory, and the1078-5884/$ – see front matter
http://dx.doi.org/10.1016/j.ejvs.2012.06.013choice of bypass or endovascular therapy for their PAD needs to
reﬂect this limited life expectancy. In PAD patients of all ages in
the BASIL trial,5 bypass with adequate greater saphenous vein
was found to be superior to angioplasty in those with a life expec-
tancy beyond two years. Regardless, the optimal therapy should
limit periprocedural morbidity and mortality, should be durable
and require few, if any, reinterventions and be successful in
resolving symptoms and avoiding major amputation. These are
complex decisions and should be individualized to the patient’s
symptoms, anatomy and comorbidities and require consideration
of both open and endovascular therapies by vascular surgeons.References
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